Colo205 In Vivo Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF629
Target Cell Organism: Human
Target Cell Alternative Name: COLO 205
Target Cell Name: Colo205
Assay Type: Oncology In Vivo Assays
Assay Overview
This assay is to provide Colo205-based In Vivo Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Colo205
Target Cell Organism
Human
Target Cell Background
The COLO 205 cell line is made up of epithelial cells isolated in 1975 from ascitic fluid derived from a White, 70-year-old, man with colon cancer. The cells can be used for cancer and toxicology research.
Target Cell Alternative Name
COLO 205
Related Diseases
Colon Cancer
Research Area
Oncology
Assay Name
In Vivo Anti-Tumor Efficacy Assay
Short Description
Colo205-cell based In Vivo Anti-Tumor Efficacy Assay
Assay Description
After positive anti-tumor efficacy data is concluded using in vitro assays, we can start to initiate in vivo anti-tumor efficacy studies. Creative Biolabs offers a wide variety of PDX or CDX models to facilitate the efficacy studies. This assy will be used to evaluate the anti-tumor efficacy of your therapeutic candidates, such as small molecules, antibodies, CARTs or other biologics. Detailed group set up and other plans will be discussed according to your specific requirements.
Assay Type
Oncology In Vivo Assays
For Research Use Only | Not For Clinical Use
Online Inquiry